Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 20/20 | 0.39 |
| ▸ | STAT3 | P40763 | 2/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | JAK1 | P23458 | 1/20 | 0.39 |
| ▸ | STAT1 | P42224 | 1/20 | 0.39 |
| ▸ | JAK3 | P52333 | 1/20 | 0.39 |
| ▸ | BMPR2 | Q13873 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30703084 | 0.96 | TYK2 (0.38) | TYK2STAT3JAK2JAK1STAT1 | |
| SCHEMBL30703094 | 0.96 | TYK2 (0.40) | TYK2STAT3JAK2JAK1STAT1 | |
| SCHEMBL30663452 | 0.94 | TYK2 (0.37) | TYK2STAT3JAK2JAK1JAK3 | |
| SCHEMBL30703096 | 0.91 | TYK2 (0.37) | TYK2STAT3JAK2JAK1STAT1 | |
| SCHEMBL29842996 | 0.87 | TYK2 (0.41) | TYK2 | |
| SCHEMBL30663443 | 0.86 | TYK2 (0.41) | TYK2STAT3JAK2JAK1STAT1 | |
| SCHEMBL30703067 | 0.86 | TYK2 (0.37) | TYK2STAT3JAK2JAK1STAT1 | |
| SCHEMBL30708170 | 0.85 | TYK2 (0.46) | TYK2STAT3JAK2JAK1STAT1 | |
| SCHEMBL30703079 | 0.85 | TYK2 (0.40) | TYK2STAT3JAK2JAK1STAT1 | |
| SCHEMBL30663439 | 0.84 | TYK2 (0.40) | TYK2STAT3JAK2JAK1STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117377669-A | TYK2 inhibitor and application thereof | 苏多生物科学有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-117377669-A | TYK2 inhibitor and application thereof | 苏多生物科学有限公司 | 2024-01-09 | — | — | CN | disclosed |